Leukocytosis as a predictor for progression to haemolytic uraemic syndrome in Escherichia coli O157:H7 infection

Archives of Disease in Childhood

Volumn 92, Issue 9, 2007, Pages 820-823

  Anjay, M A ^a   Anoop, P ^b   Britland, A ^c  

^a JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c AIREDALE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FECES ANALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; MEDICAL LITERATURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR;

CHILD; DISEASE PROGRESSION; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; LEUKOCYTOSIS;

EID: 34548493918     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.120972     Document Type: Article

References (16)

1. Subcommittee of the PHLS Advisory Committee on Gastrointestinal Infections. Guidelines for the control of infection with verocytotoxin producing Escherichia coli (VTEC). Commun Dis Public Health 2000;3(1):14-23.
2. Tserenpuntsag B, Chang HG, Smith PF, et al. Hemolytic uremic syndrome risk and Escherichia coli O157:H7. Emerg Infect Dis 2005;11(12):1955-7.
3. Wood R, Donaghy M, Dundas S. Monitoring patients in the community with suspected Escherichia coli O157 infection during a large outbreak in Scotland in 1996. Epidemiol Infect 2001;127(3):413-20.
4. Dundas S, Todd WT, Stewart AI, et al. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 2001;33(7):923-31.
5. Ikeda K, Ida O, Kimoto K, et al. Predictors for the development of haemolytic uraemic syndrome with Escherichia coli O157:H7 infections: with focus on the day of illness. Epidemiol Infect 2000;124(3):343-9.
6. Buteau C, Proulx F, Chaibou M, et al. Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome. Pediatr Infect Dis J 2000;19(7):642-7.
7. Wong CS, Jelacic S, Habeeb RL, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000;342(26):1930-6.
8. Kawamura N, Yamazaki T, Tamai H. Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome. Pediatr Int 1999;41(2):218-22.
9. Bell BP, Griffin PM, Lozano P, et al. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 1997;100(1):E12.
10. Akashi S, Joh K, Tsuji A, et al. A severe outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O157:H7 in Japan. Eur J Pediatr 1994;153(9):650-5.
11. Pavia AT, Nichols CR, Green DP, et al. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr 1990;116(4):544-51.
12. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157: H7, other enterohemorrhagic Escherichia coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991;13:60-98.
13. Morgan D, Newman CP, Hutchinson DN, et al. Verotoxin producing Escherichia coli O157 infections associated with the consumption of yoghurt. Epidemiol Infect 1993;111:181-7.
14. Fitzpatrick MM, Shah V, Trompeter RS, et al. Long term outcome of childhood haemolytic syndrome. BMJ 1991;303:489-92.
15. Fitzpatrick MM, Shah V, Filler G, et al. Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma. Pediatr Nephrol 1992;6(1):50-3.
16. MacConnachie AA, Todd WT. Potential therapeutic agents for the prevention and treatment of haemolytic uraemic syndrome in shiga toxin producing Escherichia coli infection. Curr Opin Infect Dis 2004;17(5):479- 82.